We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Hyloris Pharmaceuticals SA, has announced that its partner for Maxigesic IV, AFT Pharmaceuticals, has signed an exclusive license and distribution agreement with Hikma Pharmaceuticals for the U.S. commercialization of Maxigesic IV, a novel, patented ...